Top Markets
Coin of the day
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

TECX
Rangering i aksjer #11671
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm... Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Aksjekurs
$35.63
Sist synkronisert: 2026-08-28
Markedsverdi
$672.28M
Endring (1 dag)
-2.92%
Endring (1 år)
39.50%
Land
US
Handel Tectonic Therapeutic, Inc. (TECX)

Kategori

EPS for Tectonic Therapeutic, Inc. (TECX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Tectonic Therapeutic, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Tectonic Therapeutic, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH